Paying people to get vaccinated likely not a bad option

Publicly released:
International
CC:0
CC:0

Previously, it was believed that providing a financial incentive to get vaccinated would lead to some bad behavioural consequences, but new research from Europe says this is probably not the case. The team offered over 5,000 people in Sweden money to take the first dose of a COVID-19 vaccine, and say that the cash did not affect the timing or likelihood of them getting their second or third jab, even though they were payment-free. Additionally, they found the money had no negative effect on a person's sense of civic responsibility, their trust in vaccination providers, or perceptions about how safe and effective the vaccines would be. The team says their research could also mean that similar payments could incentivise blood donations and flu shots.

Media release

From: Springer Nature

1.  Human behaviour: Financial incentives do not undermine vaccine programmes

Paying people to get vaccinated against COVID-19 does not lead to negative behavioural consequences, a Nature study reports. This finding may have implications for policy-makers who may be considering using financial incentives to spur behavioural change.

Financial incentives are used to catalyse behaviour change in many situations, such as encouraging people to give blood or participate in clinical trials. The practice can trigger initial behaviour change, but some scientists and policy-makers caution against the use of financial incentives because of the longer-term, unintended consequences they may cause. They express concerns that, for example, the practice can erode prosocial motivations, diminish perceived safety and trust, and cause people to reduce healthy behaviours once the payments stop. However, it is difficult to measure the unintended consequences of financial incentives.

In a study involving more than 5,000 people in Sweden, Florian Schneider, Pol Campos-Mercade, Armando Meier and colleagues show that offering to pay people to take a first dose of a COVID-19 vaccine did not affect the timing or likelihood of them taking a second or third dose that is payment-free. In addition, they found no negative effect on their sense of civic responsibility, trust in vaccination providers, or perceptions about the safety and efficacy of vaccinations.

In a complementary study of more than 3,000 participants, the same team also found that informing US residents about the existence of state incentive programmes for COVID-19 vaccination had no negative consequences on the willingness of participants to take a further vaccine dose, trust in the state government, safety and efficacy perceptions of vaccines, or intentions to donate blood or to receive a flu shot. They conclude that modest financial incentives for vaccinations can be used without concerns about unintended consequences.

Journal/
conference:
Nature
Research:Paper
Organisation/s: University of Zurich, Switzerland
Funder: Swiss National Science Foundation grant no. 100018_185176 (F.H.S.), CEBI coming from the Danish National Research Foundation grant no. DNRF134 (P.C.-M.), the Chazen Institute for Global Business at Columbia Business School (S.M.), the Columbia Business School (S.M.), the Booth School of Business, University of Chicago (D.P.), the Riksbankens Jubileumsfond (E.W.) and the Swiss National Science Foundation grant no. PZ00P1_201956 (A.N.M.).
Media Contact/s
Contact details are only visible to registered journalists.